Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk

被引：0
|
作者：
Licastro, F
Pedrini, S
Ferri, C
Casadei, V
Govoni, M
Pession, A
Sciacca, FL
Veglia, F
Annoni, G
Bonafe, M
Olivieri, F
Franceschi, C
Grimaldi, LME
机构：
[1] Univ Bologna, Sch Med, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy
[2] Hosp San Raffaele, Neuroimmunol Unit, Dept Neurosci, I-20132 Milan, Italy
[3] Univ Milan, Dept Geriatr, Milan, Italy
[4] Inst Natl Ric & Ricovero Anziani, Ancona, Italy
来源：
ANNALS OF NEUROLOGY | 2000年 / 48卷 / 03期
关键词：
D O I：
10.1002/1531-8249(200009)48:3<388::AID-ANA16>3.3.CO;2-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Plasma levels of al-antichymotrypsin (ACT) and interleukin-1 beta (IL-1 beta) were increased in patients with probable Alzheimer's disease (AD). A common polymorphism within ACT and IL-IP genes affected plasma levels of ACT or IL-1 beta, and AD patients with the ACT T,T or IL-1 beta T,T genotype show-ed the highest levels of plasma ACT or IL-1 beta, respectively. The concomitant presence of the ACT T,T and IL-1 beta T,T genotypes increased the risk of AD (odds ratio: 5.606, confidence interval: 1.654-18.996) and decreased the age at onset of the disease.
引用
收藏
页码：388 / 391
页数：4
相关论文
共 50 条
  • [1] Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease:: peripheral inflammation or signals from the brain?
    Licastro, F
    Pedrini, S
    Caputo, L
    Annoni, G
    Davis, LJ
    Ferri, C
    Casadei, V
    Grimaldi, LME
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2000, 103 (01) : 97 - 102
  • [2] Implication of α1-antichymotrypsin polymorphism in familial Alzheimer's disease
    Nacmias, B
    Marcon, G
    Tedde, A
    Forleo, P
    Latorraca, S
    Piacentini, S
    Amaducci, L
    Sorbi, S
    [J]. NEUROSCIENCE LETTERS, 1998, 244 (02) : 85 - 88
  • [3] Implication of α1-antichymotrypsin polymorphism in familial Alzheimer's disease
    Nacmias, B
    Tedde, A
    Marcon, G
    Latorraca, S
    Forleo, P
    Piacentini, S
    Sorbi, S
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 457 - 457
  • [4] α1-antichymotrypsin and apolipoprotein E polymorphism in Alzheimer's disease
    Ueki, A
    Otsuka, M
    Namba, Y
    Ishii, T
    Ikeda, K
    [J]. PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 757 - 764
  • [5] α1-Antichymotrypsin gene polymorphism and susceptibility to Parkinson's disease
    Muñoz, E
    Obach, V
    Oliva, R
    Martí, MJ
    Ezquerra, M
    Pastor, P
    Ballesta, F
    Tolosa, E
    [J]. NEUROLOGY, 1999, 52 (02) : 297 - 301
  • [6] alpha 1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease
    Yoshizawa, T
    YamakawaKobayashi, K
    Hamaguchi, H
    Shoji, S
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 152 (02) : 136 - 139
  • [7] alpha(1)-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease
    Muramatsu, T
    Matsushita, S
    Arai, H
    Sasaki, H
    Higuchi, S
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (10) : 1205 - 1210
  • [8] Interleukin-1α gene polymorphism is associated with increased risk of Alzheimer's disease
    Du, YS
    Gao, F
    Zhao, LM
    Farlow, M
    Dodel, R
    Hampel, H
    Faltraco, F
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S291 - S291
  • [9] Plasma α1-antichymotrypsin in Alzheimer's disease;: relationships with APOE genotypes
    Scacchi, R
    Ruggeri, M
    Gambina, G
    Martini, MC
    Ferrari, G
    Corbo, RM
    [J]. NEUROBIOLOGY OF AGING, 2001, 22 (03) : 413 - 416
  • [10] Plasma and cerebrospinal fluid α-1-antichymotrypsin levels in Alzheimer's disease:: Correlation with cognitive impairment
    DeKosky, ST
    Ikonomovic, MD
    Wang, XY
    Farlow, M
    Wisniewski, S
    Lopez, OL
    Becker, JT
    Saxton, J
    Klunk, WE
    Sweet, R
    Kaufer, DI
    Kamboh, MI
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (01) : 81 - 90
12345